Patients with diabetes are prone to develop a distinct primary myocardial condition, diabetic cardiomyopathy, placing them at an increased risk for heart failure (1) (2) (3) . This occurs independently of hypertension, coronary artery disease, and other established causes of heart failure. Pertinent findings include increased mass, concentric changes, and diastolic dysfunction of the left ventricle (4, 5) . Such adverse remodeling is common among patients with diabetes and appears to be strongly associated with its duration, suggesting a role for persistent metabolic stress (6) (7) (8) . However, which exact components of the diabetic syndrome determine these cardiac alterations is not clear.
Moreover, most studies have investigated patients with type 2 diabetes, and it is uncertain whether patients with type 1 diabetes experience similar myocardial changes.
In keeping with this knowledge gap, the recently published study by Suran et al. examined crosssectional associations between markers of left ventricular structure and function and easily obtained anthropometric and laboratory variables, among patients with type 1 diabetes (9). Sixty-one study participants with a mean age 44 years and mean body mass index 27 kg/m 2 , without manifest cardiovascular disease or hypertension, and with a duration of diabetes >5 years (mean 18 years)
were consecutively included. Patients with chronic kidney disease stage ≥G2 or gross echocardiographic abnormalities were excluded. The investigators found body mass index to be moderately correlated with various markers of cardiac structure and diastolic function ( Figure 1 ). However, as Suran et al. also suggested, hyperglycemia may primarily exert its effects by increasing the susceptibility of the heart to other adverse stimuli (9) . This complies with the classical concept of a cardiovascular continuum, whereby both physiological aging and pathological aging due to cardiovascular risk factors such as diabetes, result in similar disturbances in left ventricular structure and function (24) (25) (26) . Indeed, in the Thousand & 1 study, those with diabetes developed adverse echocardiographic changes at a much earlier age than would otherwise be expected (16) . As such, hyperglycemia may also modify the relationship between body mass index and cardiovascular disease. Adding to this the fact that postload glucose may better predict cardiovascular morbidity and mortality than fasting glucose (28), one may have a possible explanation of why body mass index appears to be more consistently associated with abnormal echocardiography than do fasting glucose and HbA1c (27) . Other, simpler explanations for the lack of associations in the present, hypothesis-generating study may include the study participant homogeneity, including the exclusion of patients with known cardiovascular disease, and limited sample size (type 2 error). Additionally, the apparent associations with body mass index might have been exaggerated by the fact that for these particular analyses, the echocardiographic variables were not indexed for body surface area or allometrically scaled, e.g., by height 1.7 .
In conclusion, the findings reported by Suran et al. are thought-provoking and add to the notion that optimal treatment of patients with diabetes and subclinical cardiac damage may require targeting of multiple, interrelated pathways. Future studies should focus on whether weight loss and non-insulin therapy, e.g., sodium-glucose cotransporter-2 inhibitors, among patients with type 1 diabetes and overweight or obesity may improve myocardial function (29, 30) . Lastly, it remains to be determined how these patients should be monitored and whether particular subgroups may benefit from echocardiographic surveillance. 12. Nielsen ML, Pareek M, Gerke O, Leosdottir M, Nilsson PM, Olsen MH. Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is
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